SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001634432-21-000031
Filing Date
2021-05-14
Accepted
2021-05-14 07:50:33
Documents
12
Period of Report
2021-05-13
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K sbbp-20210513x8k.htm   iXBRL 8-K 75575
  Complete submission text file 0001634432-21-000031.txt   197481

Data Files

Seq Description Document Type Size
2 EX-101.SCH sbbp-20210513.xsd EX-101.SCH 3004
3 EX-101.LAB sbbp-20210513_lab.xml EX-101.LAB 16053
4 EX-101.PRE sbbp-20210513_pre.xml EX-101.PRE 10387
5 EXTRACTED XBRL INSTANCE DOCUMENT sbbp-20210513x8k_htm.xml XML 4865
Mailing Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053
Business Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053 (610) 254-9200
Strongbridge Biopharma plc (Filer) CIK: 0001634432 (see all company filings)

IRS No.: 981130690 | State of Incorp.: L2
Type: 8-K | Act: 34 | File No.: 001-37569 | Film No.: 21921962
SIC: 2834 Pharmaceutical Preparations